Spatial reference learning deficits in absence of dysfunctional working memory in the TgF344-AD rat model of Alzheimer's disease.
Benjamin B TournierCristina BarcaAïda B FallYesica GloriaLéa MeyerKelly CeyzériatPhilippe MilletPublished in: Genes, brain, and behavior (2020)
Alzheimer's disease (AD) is characterized by cognitive disorders and alterations of behavioral traits such as anhedonia and anxiety. Contribution of nonphysiological forms of amyloid and tau peptides to the onset of neurological dysfunctions remains unclear because most preclinical models only present one of those pathological AD-related biomarkers. A more recently developed model, the TgF344-AD rat has the advantage of overexpressing amyloid and naturally developing tauopathy, thus making it close to human familial forms of AD. We showed the presence of a learning dysfunction in a reference memory test, without spatial working memory impairment but with an increase in anxiety levels and a decrease in motivation to participate in the test. In the sucrose preference test, TgF344-AD rats did not show signs of anhedonia but did not increase the volume of liquid consumed when the water was replaced by sucrose solution. These behavioral phenomena were observed at an age when tau accumulation are absent, and where amyloid deposits are predominant in the hippocampus and the entorhinal cortex. Within the hippocampus itself, amyloid accumulation is heterogenous between the subiculum, the dorsal hippocampus and the ventral hippocampus. Thus, our data demonstrated heterogeneity in the appearance of various behavioral and neurochemical markers in the TgF344-AD rat. This multivariate analysis will therefore make it possible to define the stage of the pathology, to measure its evolution and the effects of future therapeutic treatments.
Keyphrases
- working memory
- transforming growth factor
- transcranial direct current stimulation
- prefrontal cortex
- oxidative stress
- cerebral ischemia
- spinal cord
- cognitive impairment
- endothelial cells
- cognitive decline
- single cell
- neuropathic pain
- dna methylation
- cerebrospinal fluid
- spinal cord injury
- blood brain barrier
- machine learning
- physical activity
- ionic liquid
- cell therapy
- deep brain stimulation
- current status
- drug induced